Literature DB >> 27123124

Predominance of M2-polarized macrophages in bladder cancer affects angiogenesis, tumor grade and invasiveness.

Hisashi Takeuchi1, Michio Tanaka2, Ayako Tanaka1, Akisa Tsunemi2, Hidenobu Yamamoto1.   

Abstract

Tumor-associated macrophages (TAMs) often assume an immunoregulatory M2 phenotype. Thus, the aim of the present study was to clarify the correlation of vascularity and TAMs, in particular the M2 phenotype in the stroma and tumor areas, with the clinical and pathological outcomes of patients with bladder cancer. The TAM counts and microvessel counts (MVCs) were determined immunohistochemically in 21 patients with bladder cancer. The number of infiltrating TAMs was measured using immunohistochemistry with anti-cluster of differentiation (CD)68 and anti-CD163 antibodies, to identify a macrophage lineage marker and an M2-polarized-specific cell surface receptor, respectively. CD68+ and CD163+ macrophages were evaluated in the stroma and tumor areas, and areas with a high density of infiltrating cell spots were counted. MVCs were determined using immunohistochemistry with anti-CD34 antibodies. The results revealed that the higher ratio of CD163+/CD68+ macrophages in the stroma, tumor and total tumor tissues were correlated with a higher stage and grade (P<0.05). In addition, the low ratio of CD68+/CD34+ microvessels was correlated with a higher stage (P<0.05). There was also a positive correlation between TAMs and MVC (r2=0.25; P<0.05). These results suggest that the TAM polarized M2 phenotype affects microvessels, pathological outcome, tumor grade and invasiveness.

Entities:  

Keywords:  M2-polarized macrophages; angiogenesis; bladder cancer; microenvironment; tumor-associated macrophages

Year:  2016        PMID: 27123124      PMCID: PMC4841030          DOI: 10.3892/ol.2016.4392

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  30 in total

1.  Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression.

Authors:  S Shimura; G Yang; S Ebara; T M Wheeler; A Frolov; T C Thompson
Journal:  Cancer Res       Date:  2000-10-15       Impact factor: 12.701

Review 2.  Expression of macrophage antigens by tumor cells.

Authors:  Ivan Shabo; Joar Svanvik
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

3.  Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer.

Authors:  Satoshi Ohno; Yumiko Ohno; Nobutaka Suzuki; Tsutomu Kamei; Koji Koike; Hiroyuki Inagawa; Chie Kohchi; Gen-Ichiro Soma; Masaki Inoue
Journal:  Anticancer Res       Date:  2004 Sep-Oct       Impact factor: 2.480

Review 4.  Inflammatory cell infiltration of tumors: Jekyll or Hyde.

Authors:  James E Talmadge; Moses Donkor; Eric Scholar
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

5.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

Review 6.  Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer.

Authors:  Xiaoqiang Tang
Journal:  Cancer Lett       Date:  2013-01-21       Impact factor: 8.679

Review 7.  Role of macrophages in tumour progression.

Authors:  K S Siveen; Girija Kuttan
Journal:  Immunol Lett       Date:  2009-03-09       Impact factor: 3.685

8.  Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis.

Authors:  B H Bochner; R J Cote; N Weidner; S Groshen; S C Chen; D G Skinner; P W Nichols
Journal:  J Natl Cancer Inst       Date:  1995-11-01       Impact factor: 13.506

Review 9.  Cytokine networks in solid human tumors: regulation of angiogenesis.

Authors:  R D Leek; A L Harris; C E Lewis
Journal:  J Leukoc Biol       Date:  1994-10       Impact factor: 4.962

10.  Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.

Authors:  Qiong-wen Zhang; Lei Liu; Chang-yang Gong; Hua-shan Shi; Yun-hui Zeng; Xiao-ze Wang; Yu-wei Zhao; Yu-quan Wei
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more
  29 in total

1.  Interaction between galectin-3 and cystinosin uncovers a pathogenic role of inflammation in kidney involvement of cystinosis.

Authors:  Tatiana Lobry; Roy Miller; Nathalie Nevo; Celine J Rocca; Jinzhong Zhang; Sergio D Catz; Fiona Moore; Lucie Thomas; Daniel Pouly; Anne Bailleux; Ida Chiara Guerrera; Marie-Claire Gubler; Wai W Cheung; Robert H Mak; Tristan Montier; Corinne Antignac; Stephanie Cherqui
Journal:  Kidney Int       Date:  2019-03-06       Impact factor: 10.612

2.  Attenuated macrophage activation mediated by microRNA-183 knockdown through targeting NR4A2.

Authors:  Fu-Han Gong; Li Long; Yong-Sheng Yang; De-Hong Shen; Yu-Song Zhang; Xue-Sheng Wang; Xue-Ping Zhang; Xiao-Qiang Xiao
Journal:  Exp Ther Med       Date:  2021-01-29       Impact factor: 2.447

3.  Mannose Receptor-positive Macrophage Infiltration Correlates with Prostate Cancer Onset and Metastatic Castration-resistant Disease.

Authors:  Jelani C Zarif; Javier A Baena-Del Valle; Jessica L Hicks; Christopher M Heaphy; Igor Vidal; Jacob Luo; Tamara L Lotan; Jody E Hooper; William B Isaacs; Kenneth J Pienta; Angelo M De Marzo
Journal:  Eur Urol Oncol       Date:  2018-10-19

4.  Identification of an immune gene-associated prognostic signature in patients with bladder cancer.

Authors:  Zhiqiang Wang; Liping Zhu; Li Li; Justin Stebbing; Zibing Wang; Ling Peng
Journal:  Cancer Gene Ther       Date:  2022-02-15       Impact factor: 5.987

5.  KLF5-induced miR-487a augments the progression of osteosarcoma cells by targeting NKX3-1 in vitro.

Authors:  Anyu Luo; Hanlin Liu; Chen Huang
Journal:  Oncol Lett       Date:  2022-06-14       Impact factor: 3.111

6.  High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder.

Authors:  Zhili Xu; Ling Wang; Jianhua Tian; Hongwei Man; Pengfei Li; Baoen Shan
Journal:  Oncol Lett       Date:  2018-03-05       Impact factor: 2.967

Review 7.  The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer.

Authors:  Nick van Dijk; Samuel A Funt; Christian U Blank; Thomas Powles; Jonathan E Rosenberg; Michiel S van der Heijden
Journal:  Eur Urol       Date:  2018-09-28       Impact factor: 20.096

8.  The Tumor Microenvironment of Bladder Cancer.

Authors:  Ken Hatogai; Randy F Sweis
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

9.  A combination of ssGSEA and mass cytometry identifies immune microenvironment in muscle-invasive bladder cancer.

Authors:  Xi Wang; Lixin Pan; Qinchen Lu; Haoxuan Huang; Chao Feng; Yuting Tao; Zhijian Li; Jiaxin Hu; Zhiyong Lai; Qiuyan Wang; Zhong Tang; Yuanliang Xie; Tianyu Li
Journal:  J Clin Lab Anal       Date:  2021-04-04       Impact factor: 2.352

Review 10.  A bi-directional dialog between vascular cells and monocytes/macrophages regulates tumor progression.

Authors:  Victor Delprat; Carine Michiels
Journal:  Cancer Metastasis Rev       Date:  2021-03-30       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.